MetaCap

Mobia Medical (MOBI) vs Avita Medical (RCEL)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Avita Medical is the larger company by market cap ($495.0 million vs $394.5 million), about 1.3 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

MOBI+0.85%RCEL+280.05%
+347%+149%-49%
May 8, 20261 yearNov 20, 2026
MOBI+0.85%RCEL+280.05%
+320%+136%-48%
May 4, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

MOBI versus RCEL key metrics
MetricMOBIRCEL
Share price$11.85$15.62
Market cap$394.50M$494.96M
1-day change-0.08%-2.31%
YTD return—+352.75%
1-year return—+312.14%
5-year return—+10.78%
EPS (TTM)$-1.75$-1.17
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$71.61M
Revenue growth (YoY)—+11.45%
Net income (latest FY)—$-48.59M
Gross margin—82.13%
Operating margin—-59.40%
Net margin—-67.85%
52-week high$15.29$18.43
52-week low$8.03$3.22
Distance from 52-week high-22.50%-15.25%
Analyst consensusnonestrong_buy
Avg. price target upside+51.90%+32.46%
Average volume214.96K417.02K
Shares outstanding33.29M31.69M
Employees167226
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Mobia Medical

MOBI stock →

Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions.

Health Care · Medical/Dental Instruments · 167 employees

About Avita Medical

RCEL stock →

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions.

Health Care · Medical/Dental Instruments · 226 employees

MOBI vs RCEL FAQ

Which is bigger, Mobia Medical or Avita Medical?

Avita Medical (RCEL) is larger, with a market capitalization of $494.96M compared with $394.50M for Mobia Medical (MOBI).

Are Mobia Medical and Avita Medical in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons